ReviewFrontiers in pediatrics2026
Sanjad-Sakati syndrome: integrated emergency care, long-term management, and expert perspectives-a narrative review.
Review in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sanjad-Sakati syndrome (SSS) is a rare autosomal recessive disorder characterized by congenital hypoparathyroidism, persistent hypocalcemia, growth retardation, and distinctive craniofacial dysmorphism. Despite its rarity, SSS is more prevalent in the Middle East due to high consanguinity rates. Its multisystem involvement-including endocrine, neurologic, respiratory, renal, dental, and immunologic systems-poses significant challenges in pediatric emergency care and long-term management. Objective: This review aims to provide a comprehensive, clinically focused overview and expert opinion on the emergency management, diagnostic evaluation, and acute and long-term treatment strategies for SSS, with an emphasis on high-risk manifestations such as hypocalcemic crises, airway instability, immune vulnerability, and difficult vascular access. Findings: Children with SSS often present with hypocalcemia, seizures, tetany, apnea, or laryngospasm, necessitating urgent calcium correction and airway stabilization. Microtubule dysfunction due to tubulin-specific chaperone E gene mutations contributes to endocrine and structural abnormalities, leading to neurodevelopmental impairment, sleep-disordered breathing, nephrocalcinosis, dental anomalies, and heightened susceptibility to infections associated with immune deficiency. Emergency care is complicated by abnormal airway anatomy, challenging intravenous access, susceptibility to sepsis, and metabolic instability. Early identification of biochemical abnormalities remains the cornerstone of diagnosis and timely stabilization. Long-term care requires lifelong calcium and vitamin D supplementation, regular metabolic monitoring, renal assessment, psychosocial support, and caregiver education. Conclusion: SSS demands clinical vigilance due to its multisystem involvement and potential for life-threatening metabolic and respiratory events. Early biochemical correction, cautious airway management, infection prevention, and coordinated multidisciplinary follow-up are critical to improving outcomes and reducing morbidity and mortality. Implementing standardized emergency protocols, family-directed action plans, and genetic counseling in high-risk populations can significantly enhance long-term prognosis for affected children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.